Yahoo Search Búsqueda en la Web

Entrar

Resultado de búsqueda

  1. www.ncbi.nlm.nih.gov › pmc › articlesPathogenesis of Pulmonary Manifestations in ANCA-Associated...

    12 de may. de 2024 · 1. Introduction. Vasculitis is a heterogeneous group of disorders with common pathophysiological mechanisms, characterized by inflammation of the blood vessels, which can present with a range of pathological features and clinical manifestations depending on the vessels affected [].The classification of vasculitis is based on the size of the affected blood vessels, with small-vessel vasculitis ...

  2. www.mdpi.com › 1422/0067/25-10 › 5278Pathogenesis of Pulmonary Manifestations in ANCA-Associated...

    12 de may. de 2024 · This review explored the underlying pathogenesis of pulmonary involvement in vasculitis, encompassing various forms such as granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), eosinophilic granulomatosis with polyangiitis (EGPA), and anti-GBM disease.

  3. radiopaedia.org › articles › eosinophilic-granulomatosis-with-polyangiitisEosinophilic granulomatosis with polyangiitis | Radiology...

    21 de may. de 2024 · Eosinophilic granulomatosis with polyangiitis (EGPA), previously known as Churg-Strauss syndrome is characterized by asthma, eosinophilia and small vessel necrotizing vasculitis and involves the lungs and other organs. Epidemiology. The incidence typically peaks in middle age, 30-50 years of age with pediatric cases being rare 2,16,24.

  4. investors.amgen.com › news-releases › news-release-detailsAMGEN HIGHLIGHTS NEW COPD, ASTHMA AND VASCULITIS RESEARCH AT ATS...

    1 de may. de 2024 · AMGEN HIGHLIGHTS NEW COPD, ASTHMA AND VASCULITIS RESEARCH AT ATS 2024. Findings From Tezspire® (tezepelumab-ekko) Phase 2a COURSE COPD Study. Phase 1 Study on AMG104/AZD8630 (Inhaled Anti-TSLP) in Moderate to Severe Asthma. New TAVNEOS® (avacopan) Data in Adults With Severe Active ANCA-Associated Vasculitis With Lung Involvement.

  5. Videos

    Ver todo

  6. www.biospace.com › article › releasesAmgen Highlights New COPD, Asthma and Vasculitis Research at ......

    1 de may. de 2024 · Amgen Highlights New COPD, Asthma and Vasculitis Research at ATS 2024. Published: May 01, 2024. Findings From Tezspire® (tezepelumab-ekko) Phase 2a COURSE COPD Study. Phase 1 Study on AMG104/AZD8630 (Inhaled Anti-TSLP) in Moderate to Severe Asthma. New TAVNEOS® (avacopan) Data in Adults With Severe Active ANCA-Associated Vasculitis ...

  7. radiopaedia.org › articles › vasculitisVasculitis | Radiology Reference Article | Radiopaedia.org

    18 de may. de 2024 · Vasculitis describes generalised inflammation of vessels. Vasculitides carry a broad range of clinical presentations and as a whole can involve almost any organ system. Pathology. Some vasculitides are due to direct vessel injury from an infectious agent.

  8. themalaysianreserve.com › 2024/05/01 › amgen-highlights-new-copd-asthma-andAMGEN HIGHLIGHTS NEW COPD, ASTHMA AND VASCULITIS RESEARCH AT ATS...

    1 de may. de 2024 · AMGEN HIGHLIGHTS NEW COPD, ASTHMA AND VASCULITIS RESEARCH AT ATS 2024. Wednesday, May 1st, 2024 at PR Newswire. Findings From Tezspire® (tezepelumab-ekko) Phase 2a COURSE COPD Study. Phase 1 Study on AMG104/AZD8630 (Inhaled Anti-TSLP) in Moderate to Severe Asthma.